UnitedHealth Group (UNH) abruptly canceled its Investor Day presentation shortly after it began this morning following media reports that the CEO of its insurance unit had been fatally shot.
Brian Thompson, who had led UNH's insurance segment since 2021, was shot in midtown Manhattan around 6:45 am Eastern Time on Wednesday morning, according to CNBC. He was transported to a local hospital in critical condition but was pronounced dead shortly thereafter.
UNH's Investor Day presentation had begun at 8:00 am Eastern Time in New York City, but quickly came to a close.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"I'm afraid that we – some of you may know we're dealing with a very serious medical situation with one of our team members," UnitedHealth Group staff said during the presentation, according to the transcript obtained by CNBC. "And as a result, I'm afraid we’re going to have to bring to a close the event today, which I'm sure you'll understand."
Ahead of the presentation, UNH provided its outlook for fiscal 2025, calling for revenue in the range of $450 billion to $455 billion and earnings per share between $29.50 to $30.00.
"Overall, the outlook is in-line with expectations and represents a solid starting point for a company that guides conservatively, though the devil will be in the details," said Oppenheimer analyst Michael Wiederhorn, who has an Outperform (Buy) rating on the Dow Jones stock.
Where does Wall Street stand on UnitedHealth?
In fact, most of Wall Street is already bullish on the blue chip stock, even as its lagged the broad market this year. Indeed, shares of UNH are up 16% since the start of 2024 on a total return basis (price change plus dividends) basis vs the S&P 500's 28.5% gain.
According to S&P Global Market Intelligence, the average analyst target price for UNH stock is $629.19, representing implied upside of nearly 3% to current levels. Additionally, the consensus recommendation is Strong Buy.
Financial services firm UBS Global Research is one of the more bullish outfits on UNH stock with a Buy rating and $650 price target.
"Following the election, a Trump presidency is likely to be favorable to Medicare Advantage with higher rate updates and less regulation," says UBS analyst AJ Rice. "This puts UNH at the forefront to benefit the most as it gains market share in 2025 while remaining in its target margin range for MA. Additionally, a Republican administration is likely to be more lenient towards anti-trust, allowing UNH to have more acquisition opportunities long term."
Related Content
-
Trump's First 100 Days: Retirement Savers Learn the Importance of Staying the CourseFrom wild stock market gyrations to emotional trading, here’s how President Trump's first 100 days have impacted retirement savers.
-
Amazon to Display Tariff Charges on Their Product ListingsHow much will tariffs increase Amazon's prices?
-
How Trump's First 100 Days Have Impacted Your PortfolioPresident Trump's first 100 days in office have been busy, with a flurry of executive orders sparking volatility in the stock and bond markets.
-
Is It Still Worth It to Gift Savings Bonds?Kiplinger editor explores if it's still a good idea to get savings bonds as gifts for children, looking at their returns and usability.
-
Don't Veer Off Course at the First Sign of a Squall in the MarketsWhen markets go nuts and investor sentiment drops, you can keep your sanity by trusting in and sticking with your long-term plan.
-
How Business Owners Can Prepare for a Terminal DiagnosisThe most important thing is readiness, whether the owner faces a life-changing diagnosis or an employee does.
-
Advisers, Take Note: How 2025 Social Security Changes May Impact Your ClientsWhat financial advisers might need to know to help their clients navigate Social Security in 2025.
-
Stock Market Today: Have We Seen the Bottom for Stocks?Solid first-quarter earnings suggest fundamentals remain solid, and recent price action is encouraging too.
-
Social Security Is Taxable, But There Are WorkaroundsIf you're strategic about your retirement account withdrawals, you can potentially minimize the taxes you'll pay on your Social Security benefits.
-
Serious Medical Diagnosis? Four Financial Steps to TakeA serious medical diagnosis calls for updates of your financial, health care and estate plans as well as open conversations with those who'll fulfill your wishes.
